Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M407640200 on July 30, 2004

J. Biol. Chem., Vol. 279, Issue 42, 43479-43486, October 15, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/42/43479    most recent
M407640200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eisen-Vandervelde, A. L.
Right arrow Articles by Hahn, Y. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eisen-Vandervelde, A. L.
Right arrow Articles by Hahn, Y. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Hepatitis C Virus Core Selectively Suppresses Interleukin-12 Synthesis in Human Macrophages by Interfering with AP-1 Activation*

Audrey L. Eisen-Vandervelde{ddagger}§, Stephen N. Waggoner{ddagger}§, Zhi Qiang Yao{ddagger}, Evan M. Cale{ddagger}, Chang S. Hahn||, and Young S. Hahn{ddagger}§¶**

From the {ddagger}Beirne Carter Center for Immunology Research and the Departments of §Microbiology and Pathology, University of Virginia, Charlottesville, Virginia 22908 and ||Immunology Platform, Aventis Pharmaceuticals, Bridgewater, NJ 08807

Hepatitis C virus (HCV) is remarkably efficient at establishing persistent infection, suggesting that it has evolved one or more strategies aimed at evading the host immune response. T cell responses, including interferon-{gamma} production, are severely suppressed in chronic HCV patients. The HCV core protein has been previously shown to circulate in the bloodstream of HCV-infected patients and inhibit host immunity through an interaction with gC1qR. To determine the role of the HCV core-gC1qR interaction in modulation of inflammatory cytokine production, we examined interleukin (IL)-12 production, which is critical for the induction of interferon-{gamma} synthesis, in lipopolysaccharide-stimulated human monocyte/macrophages. We found that core protein binds the gC1qR displayed on the cell surface of monocyte/macrophages and inhibits the production of IL-12p70 upon lipopolysaccharide stimulation. This inhibition was found to be selective in that HCV core failed to affect the production of IL-6, IL-8, IL-1{beta}, and tumor necrosis factor {alpha}. In addition, suppression of IL-12 production by core protein occurred at the transcriptional level by inhibition of IL-12p40 mRNA synthesis. Importantly, core-induced inhibition of IL-12p40 mRNA synthesis resulted from impaired activation of AP-1 rather than enhanced IL-10 production. These results suggest that the HCV core-gC1qR interaction may play a pivotal role in establishing persistent infection by dampening TH1 responses.


Received for publication, July 7, 2004 , and in revised form, July 29, 2004.

* This work was supported by National Institutes of Health Grant DK66754. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

** To whom correspondence should be addressed: Dept. of Microbiology, Pathology, and Beirne Carter Center, University of Virginia HSC, Box 801386, Charlottesville, VA 22903. Tel.: 434-924-1155; Fax: 434-924-1221; E-mail: ysh5e{at}virginia.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Xu, N. Xiao, F. Liu, H. Ren, and J. Gu
Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria
PNAS, February 3, 2009; 106(5): 1530 - 1535.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
D. L. Montgomery, A. Van Olphen, H. Van Campen, and T. R. Hansen
The Fetal Brain in Bovine Viral Diarrhea Virus-infected Calves: Lesions, Distribution, and Cellular Heterogeneity of Viral Antigen at 190 Days Gestation
Vet. Pathol., May 1, 2008; 45(3): 288 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Lukens, M. W. Cruise, M. G. Lassen, and Y. S. Hahn
Blockade of PD-1/B7-H1 Interaction Restores Effector CD8+ T Cell Responses in a Hepatitis C Virus Core Murine Model
J. Immunol., April 1, 2008; 180(7): 4875 - 4884.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. N. Waggoner, C. H. T. Hall, and Y. S. Hahn
HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production
J. Leukoc. Biol., December 1, 2007; 82(6): 1407 - 1419.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Chang, A. Dolganiuc, and G. Szabo
Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins
J. Leukoc. Biol., September 1, 2007; 82(3): 479 - 487.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. A. Byrnes, D.-Y. Li, K. Park, D. Thompson, C. Mocilnikar, P. Mohan, J. P. Molleston, M. Narkewicz, H. Zhou, S. F. Wolf, et al.
Modulation of the IL-12/IFN-{gamma} axis by IFN-{alpha} therapy for hepatitis C
J. Leukoc. Biol., March 1, 2007; 81(3): 825 - 834.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. R. Ciccaglione, E. Stellacci, C. Marcantonio, V. Muto, M. Equestre, G. Marsili, M. Rapicetta, and A. Battistini
Repression of Interferon Regulatory Factor 1 by Hepatitis C Virus Core Protein Results in Inhibition of Antiviral and Immunomodulatory Genes
J. Virol., January 1, 2007; 81(1): 202 - 214.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. N. Waggoner, M. W. Cruise, R. Kassel, and Y. S. Hahn
gC1q Receptor Ligation Selectively Down-Regulates Human IL-12 Production through Activation of the Phosphoinositide 3-Kinase Pathway
J. Immunol., October 1, 2005; 175(7): 4706 - 4714.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Matsumori
Hepatitis C Virus Infection and Cardiomyopathies
Circ. Res., February 4, 2005; 96(2): 144 - 147.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement